Literature DB >> 19740118

The effects of hormonal contraceptives on bone turnover markers and bone health.

Markus Herrmann1, Markus J Seibel.   

Abstract

Sex hormones are important regulators of bone metabolism. As hormonal contraceptives contain either oestrogens or progestins, or a combination thereof, it is conceivable that these widely used agents have an effect on bone metabolism and bone health. The main users of hormonal contraceptives, adolescent girls and young women, are still building bone and accruing bone mass and may therefore be particularly susceptible to the effects of hormonal contraceptives on bone. Despite these concerns, the effects of hormonal contraceptives on bone health are still poorly understood. As biochemical markers of bone turnover have been proven useful tools in the assessment and monitoring of bone metabolism, we reviewed the effects of combined and gestagen-only hormonal contraceptives on bone turnover markers and related effects on bone mineral density and fracture risk in premenopausal women, as documented in the literature until January 2009.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19740118     DOI: 10.1111/j.1365-2265.2009.03688.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  11 in total

Review 1.  Oral contraceptive use and bone.

Authors:  Shuying Wei; Tania Winzenberg; Laura L Laslett; Alison Venn; Graeme Jones
Journal:  Curr Osteoporos Rep       Date:  2011-03       Impact factor: 5.096

2.  Oral contraceptive use and fracture risk-a retrospective study of 12,970 women in the UK.

Authors:  S Dombrowski; L Jacob; P Hadji; K Kostev
Journal:  Osteoporos Int       Date:  2017-04-13       Impact factor: 4.507

3.  Acute bone marker responses to whole-body vibration and resistance exercise in young women.

Authors:  Vanessa D Sherk; Carmen Chrisman; Jessica Smith; Kaelin C Young; Harshvardhan Singh; Michael G Bemben; Debra A Bemben
Journal:  J Clin Densitom       Date:  2012-08-16       Impact factor: 2.617

4.  The impact of depot medroxyprogesterone acetate on fracture risk: a case-control study from the UK.

Authors:  I Kyvernitakis; K Kostev; T Nassour; F Thomasius; P Hadji
Journal:  Osteoporos Int       Date:  2016-07-26       Impact factor: 4.507

5.  Bone metabolism in adolescent girls with eating disorders and weight loss: independent effects of weight change, insulin-like growth factor-1 and oestradiol.

Authors:  Ingemar Swenne; Mats Stridsberg
Journal:  Eat Weight Disord       Date:  2014-08-28       Impact factor: 4.652

Review 6.  Steroidal contraceptives and bone fractures in women: evidence from observational studies.

Authors:  Laureen M Lopez; Mario Chen; Sarah Mullins Long; Kathryn M Curtis; Frans M Helmerhorst
Journal:  Cochrane Database Syst Rev       Date:  2015-07-21

7.  Vaginally administered PEGylated LIF antagonist blocked embryo implantation and eliminated non-target effects on bone in mice.

Authors:  Ellen Menkhorst; Jian-Guo Zhang; Natalie A Sims; Phillip O Morgan; Priscilla Soo; Ingrid J Poulton; Donald Metcalf; Estella Alexandrou; Melissa Gresle; Lois A Salamonsen; Helmut Butzkueven; Nicos A Nicola; Evdokia Dimitriadis
Journal:  PLoS One       Date:  2011-05-18       Impact factor: 3.240

8.  Effects of whole-body vibration on acute bone turnover marker responses to resistance exercise in young men.

Authors:  D A Bemben; P Sharma-Ghimire; Z Chen; E Kim; D Kim; M G Bemben
Journal:  J Musculoskelet Neuronal Interact       Date:  2015-03       Impact factor: 2.041

9.  Effect of two combinations of low-dose oral contraceptives on adolescent bone mass: A clinical trial with 2 years follow-up.

Authors:  Talita Domingues Caldeirão; Lilian Rodrigues Orsolini; Carla Cristiane da Silva; Anapaula da Conceição Bisi Rizzo; Altamir Santos Teixeira; Hélio Rubens de Carvalho Nunes; Tamara Beres Lederer Goldberg
Journal:  Medicine (Baltimore)       Date:  2022-09-16       Impact factor: 1.817

Review 10.  Bone health in estrogen-free contraception.

Authors:  P Hadji; E Colli; P-A Regidor
Journal:  Osteoporos Int       Date:  2019-08-24       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.